Related Experiment Video
Updated: Jun 27, 2025

12:16
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
21.3K
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
Alessandra Loda1, Francesco Semeraro2, Silvia Parolini3
1Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Biochimica Et Biophysica Acta. Reviews on Cancer
|May 3, 2024
Summary
Uveal melanoma (UM) is a common eye tumor. Cancer stem-like cells (CSCs) drive treatment resistance and metastasis in UM, highlighting them as potential therapeutic targets.
Area of Science:
- Ophthalmology
- Oncology
- Cancer Biology
Background:
- Uveal melanoma (UM) is the most frequent primary ocular tumor in adults.
- While primary UM is treatable, ~50% of patients develop life-threatening liver metastasis.
- Current therapies show limited efficacy against UM metastasis and resistance.
Purpose of the Study:
- To review the current understanding of cancer stem-like cell (CSC) biology in UM.
- To explore the role of CSCs in UM treatment failure and metastasis.
- To discuss CSCs as potential therapeutic targets for UM.
Main Methods:
- Literature review of preclinical and clinical studies on UM and CSCs.
- Analysis of molecular pathways and mechanisms associated with UM CSCs.
- Synthesis of current knowledge on CSC biology in uveal melanoma.
Main Results:
- CSCs are identified as a key factor in UM resistance to chemotherapy and targeted therapies.
- CSCs contribute significantly to the hematological dissemination and metastasis of UM.
- Emerging research has identified specific molecular pathways in UM CSCs.
Conclusions:
- CSCs represent a major challenge in treating uveal melanoma effectively.
- Targeting CSCs holds promise for overcoming therapeutic resistance and improving patient survival.
- Further research into UM CSC biology is crucial for developing novel treatment strategies.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
3.5K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

